Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks

At the moment, little treatment options are available for Duchenne muscular dystrophy (DMD). The absence of the dystrophin protein leads to a complex cascade of pathogenic events in myofibres, including chronic inflammation and oxidative stress as well as altered metabolism. The attention towards di...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pharmacol Res
Main Authors: Boccanegra, Brigida, Verhaart, Ingrid E.C., Cappellari, Ornella, Vroom, Elizabeth, De Luca, Annamaria
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier Ltd. 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7261230/
https://ncbi.nlm.nih.gov/pubmed/32485610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2020.104917
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares